Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Roger

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Immunity, Inflammation and Disease|April 28, 2022
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational studyClara Padró, Diego Gutiérrez, Francisco Moreno, et al.
Advances in Therapy|June 18, 2016
Comprehensive Study of Patients' Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic RhinitisAlfonso Malet, Angel Azpeitia, Diego Gutiérrez, et al.
Immunotherapy|January 9, 2020
Real-life effect of a microcrystalline tyrosine adjuvanted mite immunotherapy in patients with allergic rhinitisAlbert Roger, Alfons Malet, Victoria Moreno, et al.
The World Allergy Organization Journal|June 28, 2021
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapyJosé L Justicia, Clara Padró, Albert Roger, et al.
Frontiers in Immunology|September 4, 2024
Peripheral blood T-cell modulation by omalizumab in chronic urticaria patientsCristina López, Nathalie Depreux, Isabel Bielsa, et al.
Journal of Market Access & Health Policy|April 29, 2016
A review of the value of innovation in inhalers for COPD and asthmaJohann Christian Virchow, Cezmi A Akdis, Josep Darba, et al.
Annals of Medicine|February 16, 2024
Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysisMaria Basagaña, Carlos Martínez-Rivera, Clara Padró, et al.
Journal of Personalized Medicine|July 29, 2023
Characterization and Factors Associated with Poor Asthma Control in Adults with Severe Eosinophilic AsthmaClara Padró-Casas, María Basagaña, María Luisa Rivera-Ortún, et al.
Immunotherapy|January 13, 2016
Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergyVictoria Moreno, Marta Alvariño, Fernando Rodríguez, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunity, Inflammation and Disease|April 28, 2022
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational studyClara Padró, Diego Gutiérrez, Francisco Moreno, et al.
Advances in Therapy|June 18, 2016
Comprehensive Study of Patients' Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic RhinitisAlfonso Malet, Angel Azpeitia, Diego Gutiérrez, et al.
Immunotherapy|January 9, 2020
Real-life effect of a microcrystalline tyrosine adjuvanted mite immunotherapy in patients with allergic rhinitisAlbert Roger, Alfons Malet, Victoria Moreno, et al.
The World Allergy Organization Journal|June 28, 2021
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapyJosé L Justicia, Clara Padró, Albert Roger, et al.
Frontiers in Immunology|September 4, 2024
Peripheral blood T-cell modulation by omalizumab in chronic urticaria patientsCristina López, Nathalie Depreux, Isabel Bielsa, et al.
Journal of Market Access & Health Policy|April 29, 2016
A review of the value of innovation in inhalers for COPD and asthmaJohann Christian Virchow, Cezmi A Akdis, Josep Darba, et al.
Annals of Medicine|February 16, 2024
Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysisMaria Basagaña, Carlos Martínez-Rivera, Clara Padró, et al.
Journal of Personalized Medicine|July 29, 2023
Characterization and Factors Associated with Poor Asthma Control in Adults with Severe Eosinophilic AsthmaClara Padró-Casas, María Basagaña, María Luisa Rivera-Ortún, et al.
Immunotherapy|January 13, 2016
Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergyVictoria Moreno, Marta Alvariño, Fernando Rodríguez, et al.
Pageof 2